Medeor Therapeutics' Series B Round

Medeor Therapeutics raised a round of funding on November 27, 2017.

Medeor Therapeutics is a clinical-stage biotechnology company dedicated to the discovery, development and commercialization of transformative and personalized cellular immunotherapies to improve outco…

Articles about Medeor Therapeutics' Series B Round: